Literature DB >> 16198615

Syndecan-2.

Jeffrey J Essner1, Eleanor Chen, Stephen C Ekker.   

Abstract

The members of the Syndecan family of heparan sulfate proteoglycans play diverse roles in cell adhesion and cell communication by serving as co-receptors for both cell-signaling and extracellular matrix molecules. Syndecan-2 has been implicated in the formation of specialized membrane domains and functions as a direct link between the extracellular environment and the organization of the cortical cytoplasm. Recent studies have shown that syndecan-2 is required for angiogenesis, possibly by serving as a co-receptor for vascular endothelial growth factor, and cell-to-cell signaling during development of left-right asymmetry. This unique combination of activities suggests that syndecan-2 can function as a potential drug target for the development of multi-functional, anti-cancer therapeutics.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 16198615     DOI: 10.1016/j.biocel.2005.08.012

Source DB:  PubMed          Journal:  Int J Biochem Cell Biol        ISSN: 1357-2725            Impact factor:   5.085


  31 in total

1.  Estradiol-estrogen receptor: a key interplay of the expression of syndecan-2 and metalloproteinase-9 in breast cancer cells.

Authors:  Olga Ch Kousidou; Aikaterini Berdiaki; Dimitris Kletsas; Alexandros Zafiropoulos; Achilleas D Theocharis; George N Tzanakakis; Nikos K Karamanos
Journal:  Mol Oncol       Date:  2008-06-18       Impact factor: 6.603

Review 2.  Role of syndecan-2 in osteoblast biology and pathology.

Authors:  Rafik Mansouri; Eric Haÿ; Pierre J Marie; Dominique Modrowski
Journal:  Bonekey Rep       Date:  2015-04-01

3.  Reciprocal regulation of syndecan-2 and Notch signaling in vascular smooth muscle cells.

Authors:  Ning Zhao; Hua Liu; Brenda Lilly
Journal:  J Biol Chem       Date:  2012-03-21       Impact factor: 5.157

4.  Effects of doxorubicin-encapsulating AG73 peptide-modified liposomes on tumor selectivity and cytotoxicity.

Authors:  Yoichi Negishi; Nobuhito Hamano; Daiki Omata; Azusa Fujisawa; Maya Manandhar; Motoyoshi Nomizu; Yukihiko Aramaki
Journal:  Results Pharma Sci       Date:  2011-10-13

5.  Syndecan-2 cytoplasmic domain up-regulates matrix metalloproteinase-7 expression via the protein kinase Cγ-mediated FAK/ERK signaling pathway in colon cancer.

Authors:  Bohee Jang; Hyejung Jung; Sojoong Choi; Young Hun Lee; Seung-Taek Lee; Eok-Soo Oh
Journal:  J Biol Chem       Date:  2017-08-16       Impact factor: 5.157

Review 6.  Pleiotrophin: Activity and mechanism.

Authors:  Xu Wang
Journal:  Adv Clin Chem       Date:  2020-03-12       Impact factor: 5.394

Review 7.  Emerging Role of Syndecans in Extracellular Matrix Remodeling in Cancer.

Authors:  Bohee Jang; Ayoung Kim; Jisun Hwang; Hyun-Kuk Song; Yunjeon Kim; Eok-Soo Oh
Journal:  J Histochem Cytochem       Date:  2020-07-06       Impact factor: 2.479

8.  Runx2 transcriptome of prostate cancer cells: insights into invasiveness and bone metastasis.

Authors:  Sanjeev K Baniwal; Omar Khalid; Yankel Gabet; Ruchir R Shah; Daniel J Purcell; Deepak Mav; Alice E Kohn-Gabet; Yunfan Shi; Gerhard A Coetzee; Baruch Frenkel
Journal:  Mol Cancer       Date:  2010-09-23       Impact factor: 27.401

9.  Comparative genome-wide DNA methylation analysis of colorectal tumor and matched normal tissues.

Authors:  Femke Simmer; Arie B Brinkman; Yassen Assenov; Filomena Matarese; Anita Kaan; Lina Sabatino; Alberto Villanueva; Dori Huertas; Manel Esteller; Thomas Lengauer; Christoph Bock; Vittorio Colantuoni; Lucia Altucci; Hendrik G Stunnenberg
Journal:  Epigenetics       Date:  2012-10-18       Impact factor: 4.528

Review 10.  The signaling mechanisms of syndecan heparan sulfate proteoglycans.

Authors:  Kathleen Lambaerts; Sarah A Wilcox-Adelman; Pascale Zimmermann
Journal:  Curr Opin Cell Biol       Date:  2009-06-15       Impact factor: 8.382

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.